Biosynthesis of heme in mammals.

Most iron in mammalian systems is routed to mitochondria to serve as a substrate for ferrochelatase. Ferrochelatase inserts iron into protoporphyrin IX to form heme which is incorporated into hemoglobin and cytochromes, the dominant hemoproteins in mammals. Tissue-specific regulatory features characterize the heme biosynthetic pathway. In erythroid cells, regulation is mediated by erythroid-specific transcription factors and the availability of iron as Fe/S clusters. In non-erythroid cells the pathway is regulated by heme-mediated feedback inhibition. All of the enzymes in the heme biosynthetic pathway have been crystallized and the crystal structures have permitted detailed analyses of enzyme mechanisms. All of the genes encoding the heme biosynthetic enzymes have been cloned and mutations of these genes are responsible for a group of human disorders designated the porphyrias and for X-linked sideroblastic anemia. The biochemistry, structural biology and the mechanisms of tissue-specific regulation are presented in this review along with the key features of the porphyric disorders.

[1]  N. Andrews,et al.  A mouse model of familial porphyria cutanea tarda. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Kohno,et al.  Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins. , 1995, Journal of biochemistry.

[3]  B. Grandchamp,et al.  A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria. , 1995, Human molecular genetics.

[4]  M. Badminton,et al.  Molecular mechanisms of dominant expression in porphyria , 2005, Journal of Inherited Metabolic Disease.

[5]  B. Grandchamp,et al.  Homozygous hereditary coproporphyria caused by an arginine to tryptophane substitution in coproporphyrinogen oxidase and common intragenic polymorphisms. , 1994, Human molecular genetics.

[6]  M. Badminton,et al.  Liver transplantation as a cure for acute intermittent porphyria , 2004, The Lancet.

[7]  Jiandie D. Lin,et al.  Nutritional Regulation of Hepatic Heme Biosynthesis and Porphyria through PGC-1α , 2005, Cell.

[8]  D. Brenner,et al.  A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene. , 1994, The Journal of biological chemistry.

[9]  Y. Adachi,et al.  Regulation of the expression of human ferrochelatase by intracellular iron levels. , 2000, European journal of biochemistry.

[10]  C. Beaumont,et al.  Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. , 1996, American journal of human genetics.

[11]  M. Owen,et al.  Partial characterization and assignment of the gene for protoporphyrinogen oxidase and variegate porphyria to human chromosome 1q23. , 1995, Human molecular genetics.

[12]  P. Giampietro,et al.  Regional gene assignment of human porphobilinogen deaminase and esterase A4 to chromosome 11q23 leads to 11qter. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Klasen,et al.  Genetic aspects of erythropoietic protoporphyria , 1984, Annals of human genetics.

[14]  J. Rose,et al.  The 2.0 Å structure of human ferrochelatase, the terminal enzyme of heme biosynthesis , 2001, Nature Structural Biology.

[15]  R. Desnick,et al.  δ‐Aminolevulinic Acid Dehydratase Isozymes and Lead Toxicity a , 1987 .

[16]  K. Furuyama,et al.  Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. , 2004, Journal of biochemistry.

[17]  M. Worwood,et al.  Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload , 1998, Hepatology.

[18]  J. Deybach,et al.  Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. , 1999, American journal of human genetics.

[19]  D. Steensma,et al.  Congenital Erythropoietic Porphyria, β-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation. , 2005 .

[20]  M. Mattei,et al.  Assignment of human uroporphyrinogen decarboxylase (URO-D) to the p34 band of chromosome 1 , 1986, Human Genetics.

[21]  J. Phillips,et al.  Uroporphyria in the uroporphyrinogen decarboxylase‐deficient mouse: Interplay with siderosis and polychlorinated biphenyl exposure , 2002, Hepatology.

[22]  D. Schomburg,et al.  Uroporphyrinogen-III synthase , 1990 .

[23]  C. Hill,et al.  Crystal structure of human uroporphyrinogen decarboxylase , 1998, The EMBO journal.

[24]  B. Strandvik,et al.  Liver Transplantation in a Boy with Acute Porphyria Due to Aminolaevulinate Dehydratase Deficiency , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[25]  J. Cooper,et al.  X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 A resolution. , 1999, Biochemistry.

[26]  Dieter Jahn,et al.  Crystal structure of 5‐aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans , 2005, The EMBO journal.

[27]  P. Meissner,et al.  Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria. , 1993, The Journal of clinical investigation.

[28]  S. Takahashi,et al.  Differential regulation of coproporphyrinogen oxidase gene between erythroid and nonerythroid cells. , 1998, Blood.

[29]  H. Bonkovsky,et al.  Recommendations for the Diagnosis and Treatment of the Acute Porphyrias , 2005, Annals of Internal Medicine.

[30]  K. Astrin,et al.  Congenital erythropoietic porphyria: advances in pathogenesis and treatment , 2002, British journal of haematology.

[31]  S. Sassa,et al.  Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone. , 1983, The Journal of clinical investigation.

[32]  K. Anderson,et al.  Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations. , 2002, Journal of the American Academy of Dermatology.

[33]  R. Scarpulla,et al.  Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Elder Genetic defects in the porphyrias: types and significance. , 1998, Clinics in dermatology.

[35]  A. Smith,et al.  Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase. , 1979, The Biochemical journal.

[36]  E. Cánepa,et al.  Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin. , 2001, Experimental cell research.

[37]  G. Elder,et al.  Alternative splicing and tissue-specific transcription of human and rodent ubiquitous 5-aminolevulinate synthase (ALAS1) genes. , 2001, Biochimica et biophysica acta.

[38]  P. Martásek,et al.  Structural basis of hereditary coproporphyria. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Anderson Disorders of heme biosynthesis : X-linked sideroblastic anemia and the porphyrias , 2001 .

[40]  R. Desnick,et al.  Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression. , 2000, Genomics.

[41]  E. Jaffe,et al.  5-Chlorolevulinate modification of porphobilinogen synthase identifies a potential role for the catalytic zinc. , 1992, Biochemistry.

[42]  R. Desnick,et al.  delta-Aminolevulinic acid dehydratase isozymes and lead toxicity. , 1987, Annals of the New York Academy of Sciences.

[43]  J. Deybach,et al.  Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. , 1999, Blood.

[44]  J. Inazawa,et al.  Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. , 1992, European journal of biochemistry.

[45]  I. Glass,et al.  Molecular Genetics of Congenital Erythropoietic Porphyria , 1998, Seminars in liver disease.

[46]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[47]  R. Errington,et al.  Identification of sequences required for the import of human protoporphyrinogen oxidase to mitochondria. , 2004, The Biochemical journal.

[48]  Geraint T. Williams,et al.  Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells. , 2006, Blood.

[49]  N. Carter,et al.  Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. , 1991, Genomics.

[50]  E. Cánepa,et al.  Hepatic Nuclear Factor 3 and Nuclear Factor 1 Regulate 5-Aminolevulinate Synthase Gene Expression and Are Involved in Insulin Repression* , 2004, Journal of Biological Chemistry.

[51]  M. Timko,et al.  Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. , 1993, Science.

[52]  R. Desnick,et al.  Human delta-aminolevulinate dehydratase (ALAD) gene: structure and alternative splicing of the erythroid and housekeeping mRNAs. , 1994, Genomics.

[53]  S. Hasnain,et al.  Two different zinc sites in bovine 5-aminolevulinate dehydratase distinguished by extended X-ray absorption fine structure. , 1990, Biochemistry.

[54]  H. Dailey,et al.  In situ conversion of coproporphyrinogen to heme by murine mitochondria: Terminal steps of the heme biosynthetic pathway , 1993, Protein science : a publication of the Protein Society.

[55]  R. Whittington,et al.  Pyridoxine Responsive Anemia in the Human Adult.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[56]  J. Bloomer The liver in protoporphyria , 1988, Hepatology.

[57]  Robert Huber,et al.  Crystal structure of protoporphyrinogen IX oxidase: a key enzyme in haem and chlorophyll biosynthesis , 2004, The EMBO journal.

[58]  D W Heinz,et al.  High resolution crystal structure of a Mg2+-dependent porphobilinogen synthase. , 1999, Journal of molecular biology.

[59]  J. Deybach,et al.  Recovery from a variegate porphyria by a liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[60]  D. Brenner,et al.  Analysis of the human ferrochelatase promoter in transgenic mice. , 1998, Blood.

[61]  J. Phillips,et al.  Fast track to the porphyrias , 2005, Nature Medicine.

[62]  J. Prchal,et al.  Regulation of ferrochelatase gene expression by hypoxia. , 2004, Life sciences.

[63]  C. Hill,et al.  Crystal structure of human uroporphyrinogen III synthase , 2001, The EMBO journal.

[64]  T. Rouault,et al.  Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis , 2005, Nature Reviews Molecular Cell Biology.

[65]  T. Yoshinaga,et al.  Coproporphyrinogen oxidase. II. Reaction mechanism and role of tyrosine residues on the activity. , 1980, The Journal of biological chemistry.

[66]  P. Romeo,et al.  Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. , 1986, The Journal of biological chemistry.

[67]  J. Helliwell,et al.  Time-resolved and static-ensemble structural chemistry of hydroxymethylbilane synthase. , 2003, Faraday discussions.

[68]  H. Inokuchi,et al.  Induction of terminal enzymes for heme biosynthesis during differentiation of mouse erythroleukemia cells. , 1995, European journal of biochemistry.

[69]  T. Cox,et al.  Transcriptional Regulation of the Human Erythroid 5-Aminolevulinate Synthase Gene , 1997, The Journal of Biological Chemistry.

[70]  P. Anderson,et al.  Purification and properties of delta-aminolevulinate dehydrase from human erythrocytes. , 1979, The Journal of biological chemistry.

[71]  D. Richardson,et al.  Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.

[72]  F. Fougerousse,et al.  Localization of the human coproporphyrinogen oxidase gene to chromosome band 3q12 , 1994, Human Genetics.

[73]  C. Elferink,et al.  Regulation of 5-aminolevulinate synthase mRNA in different rat tissues. , 1988, The Journal of biological chemistry.

[74]  J. Phillips,et al.  Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. , 2000, Blood.

[75]  B. Paw,et al.  Deficiency of glutaredoxin 5 reveals Fe–S clusters are required for vertebrate haem synthesis , 2005, Nature.

[76]  R. Desnick,et al.  Uroporphyrinogen III Synthase , 2000, The Journal of Biological Chemistry.

[77]  J. G. Straka,et al.  Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase. , 1983, Biochemistry.

[78]  J. Deybach,et al.  Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France , 1997, Journal of internal medicine.

[79]  P. Labbé,et al.  Human coproporphyrinogen oxidase. Biochemical characterization of recombinant normal and R231W mutated enzymes expressed in E. coli as soluble, catalytically active homodimers. , 1997, Cellular and molecular biology.

[80]  P. Labbé,et al.  Crystal Structure of the Oxygen-dependant Coproporphyrinogen Oxidase (Hem13p) of Saccharomyces cerevisiae* , 2004, Journal of Biological Chemistry.

[81]  P. Goodfellow,et al.  Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2→q26.3 , 2005, Human Genetics.

[82]  P. Romeo,et al.  Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[83]  H. Dailey,et al.  Examination of mitochondrial protein targeting of haem synthetic enzymes: in vivo identification of three functional haem-responsive motifs in 5-aminolaevulinate synthase. , 2005, The Biochemical journal.

[84]  M. Gross,et al.  Assignment of the gene for uroporphyrinogen decarboxylase to human chromosome 1 by somatic cell hybridization and specific enzyme immunoassay , 2004, Human Genetics.

[85]  Masayuki Yamamoto,et al.  Differential Regulation of Coproporphyrinogen Oxidase Gene Between Erythroid and Nonerythroid Cells , 1998 .

[86]  S. Takahashi,et al.  Cloning of a coproporphyrinogen oxidase promoter regulatory element binding protein. , 2000, Biochemical and biophysical research communications.

[87]  P. Shoolingin-Jordan,et al.  Human porphobilinogen deaminase mutations in the investigation of the mechanism of dipyrromethane cofactor assembly and tetrapyrrole formation. , 2003, Biochemical Society transactions.

[88]  H. Inokuchi,et al.  The human protoporphyrinogen oxidase gene (PPOX): organization and location to chromosome 1. , 1995, Genomics.

[89]  A. Corrigall,et al.  A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria , 1996, Nature Genetics.

[90]  D. Bevan,et al.  Mechanism of porphobilinogen synthase. Requirement of Zn2+ for enzyme activity. , 1980, The Journal of biological chemistry.

[91]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[92]  J. Phillips,et al.  Accelerated development of uroporphyria in mice heterozygous for a deletion at the uroporphyrinogen decarboxylase locus , 2001, Journal of biochemical and molecular toxicology.

[93]  C. Beaumont,et al.  Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. , 1987, European journal of biochemistry.

[94]  C. Hill,et al.  Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase , 2003, The EMBO journal.

[95]  G. Barnard,et al.  Mechanism of porphobilinogen synthase. Possible role of essential thiol groups. , 1977, The Journal of biological chemistry.

[96]  P. Romeo,et al.  Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[97]  H. Willard,et al.  Assignment of human erythroid delta-aminolevulinate synthase (ALAS2) to a distal subregion of band Xp11.21 by PCR analysis of somatic cell hybrids containing X; autosome translocations. , 1992, Genomics.

[98]  J. McGrath,et al.  Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband. , 1998, The Journal of investigative dermatology.

[99]  H. Bonkovsky,et al.  Liver transplantation for erythropoietic protoporphyria liver disease , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[100]  J. Kushner,et al.  Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect. , 1977, Seminars in hematology.

[101]  E. Cable,et al.  Regulation of heme metabolism in rat hepatocytes and hepatocyte cell lines: delta-aminolevulinic acid synthase and heme oxygenase are regulated by different heme-dependent mechanisms. , 2000, Archives of biochemistry and biophysics.

[102]  R. Desnick,et al.  Human δ-aminolevulinate dehydratase: chromosomal localization to 9q34 by in situ hybridization , 1987, Human Genetics.

[103]  G. Sutherland,et al.  Erythroid 5-aminolevulinate synthase is located on the X chromosome. , 1990, American journal of human genetics.

[104]  M. Wessling-Resnick Iron transport. , 2000, Annual review of nutrition.

[105]  A. Roberts,et al.  An alternatively‐spliced exon in the 5′‐UTR of human ALAS1 mRNA inhibits translation and renders it resistant to haem‐mediated decay , 2005, FEBS letters.

[106]  J. Deybach,et al.  Molecular characterization of homozygous variegate porphyria. , 1998, Human molecular genetics.

[107]  P. Romeo,et al.  Structure of the gene for human uroporphyrinogen decarboxylase. , 1987, Nucleic acids research.

[108]  J. Rose,et al.  Human ferrochelatase: crystallization, characterization of the [2Fe-2S] cluster and determination that the enzyme is a homodimer. , 1999, Biochimica et biophysica acta.

[109]  M. Fleming The genetics of inherited sideroblastic anemias. , 2002, Seminars in hematology.

[110]  D. Brown,et al.  Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. , 1993, Gastroenterology.